terns, and the genes involved in these processes1-9. In this article, we focus on the bac- 
Mode of action of lantlbiotics: nisin
Nisin is the only lantibiotic produced by L. luctis for which the mode of action has been studied. It is active against a broad spectrum of Gram-positive bacteria; Escherichia coli and other Gram-negative bacteria are only affected when their outer membranes are weakened or disrupted by treatment with EDTA or osmotic shock21,22, which makes their inner membrane accessible to the lantibiotic.
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Nisin has a dual activity against spore-forming bacteria: it inhibits the outgrowth of spores and kills cells in the vegetative state. The 2,3_didehydroamino acid residues in nisin are thought to act against spores by interacting with the membrane sulfhydryl groups of germinating spores 23. The primary target of nisin in vegetative cells is the cytoplasmic membrane. It dissipates the membrane potential of whole cells, cytoplasmic membrane vesicles and artificial membrane vesicles ( liposomes)24125, indicating that the peptide does not require a specific receptor protein for activity or for membrane insertion.
Early work on the mode of action described a voltage-dependent depolarization of the membrane by nisin25. Garcer6 et ai. concluded that the membrane potential is not essential, but that the total protonmotive force stimulates the action of nisin26. However, recent work from the same group has shown that a membrane potential is essential in a different membrane system2'. Membrane disruption is believed to result from the incorporation of nisin into the cytoplasmic membrane to form an ion channel or pore. The efficiency of insertion of nisin into liposomes depends on the phospholipid composition of the liposomes. This may account for the differences in sensitivity seen between bacterial species or strains, as permeabilization only occurs in liposomes that contain zwitterionic phospholipids28T2p.
The activity of nisin can be significantly reduced by di-and trivalent cations, and activity can even be prevented by gadolinium (Gd3+)2p, a lanthanide that is known to inhibit various channels in eukaryotic and prokaryotic cells 30. Binding these ions neutralizes the negatively charged head groups of phospholipids and makes the lipids condense, resulting in a more rigid membrane, which probably decreases the efficiency with which nisin inserts and forms pores. Nisin also has a lower activity at temperatures below 7°C (Ref. 29) , presumably because increased ordering of the lipid hydrocarbon chains in the cytoplasmic membrane inhibits nisin insertion.
Mode of action of non-Iantibiotics Diplococcin
The effect of purified diplococcin from L. lactis subsp. Small pores allow leakage of protons and other small ions only, whereas amino acids leak through larger pores. (c) The bacteriocin receptor may participate in the formation of the pore. The carboxyl terminus of nisin is thought to form an a helix, and may form pores in a similar manner to that described for the lactococcins. However, no receptor is required for nisin activity.
equivalent to lactococcin A (Ref. 32) , and these effects are thought to be due to an increase in the permeability of the bacterial cytoplasmic membrane (see later section).
Lactostrepcin 5
Lactostrepcin 5 (Las.5) and other lactostrepcins have a strong and rapid bactericidal effect on sensitive cells33; only Las5 has been characterized in detail. It inhibits uridine uptake and causes leakage of K+ ions and ATP from cells. Like diplococcin, Las5 inhibits DNA, RNA and protein synthesis, probably by the inhibition of transport of precursors required for macromolecular synthesis, energy depletion of the cell and/or leakage from the cell of small solutes that are required for various metabolic activities. Las5 is equally active against energized and energy-depleted cells33.
Lactococcins A and B
Lactococcins A and B specifically inhibit the growth of lactococci. They belong to a group of small, cationic hydrophobic peptides (including several lantibiotics) that permeabilize membranes28934"6. The mode of action of purified lactococcin A has been studied using whole cells of sensitive lactococcal strains and membrane vesicles made from such cells, and also using liposomes obtained from lactococcal phospholipids3'. Similar studies on whole cells have also been done using partially purified lactococcin B (Ref. 38) . At lactococcin concentrations that do not affect cells that are immune to these peptides, both bacteriocins rapidly dissipate the membrane potential (lactococcin B also dissipates the pH gradient across the cytoplasmic membrane) of energized sensitive cells37,38. Furthermore, the addition of either lactococcin to sensitive cells that have accumulated glutamate or a-amino isobutyric acid (a non-metabolizable alanine analog) results in the immediate efflux of the amino acid, even when the proton-motive force has been dissipated before the bacteriocin is added. These results indicate that both lactococcins form pores in the cytoplasmic membrane in a voltage-independent manner. Lactococcal cells that have been gently pretreated with lysozyme release the intracellular enzyme lactate dehydrogenase within a few minutes of lactococcin A treatment39. Lactococcin A inhibits leucine uptake in cytoplasmic membrane vesicles from sensitive lactococcal cells, but not in vesicles derived from membranes of Bacillus subtilis, Clostridium acetobutylicum or E. coli3'. In contrast to the effect of nisin, liposomes derived from lactococcal phospholipids are not affected by lactococcin A.
From these data, and the fact that lactococcin A specifically inhibits lactococcal strains, Van Belkum and colleagues concluded that lactococcin A forms pores in the cytoplasmic membrane of sensitive cells using a Lactococcus-specific receptor protein3'. A 21 amino acid sequence between residues Ala30 and Phe50 in lactococcin A could form a membrane-spanning helix39 (Fig. la) , and lactococcin A may insert into the cytoplasmic membrane of sensitive cells with this hypothetical, transmembrane helical segment. In lactococcin B, there is a putative amphiphilic a helix between residues Ile28 and Phe46 (Fig. lb) , which is in a similar position to that of the putative transmembrane helix in lactococcin A.
A large number of pore-forming toxins are known to form channels by the molecules aggregating like barrel staves around a central water-filled pore40,41 (Fig. 2a) , and nisin and the lactococcins A and B are thought to act in this way. The size of the pore would be determined by the number of molecules involved (Fig. 2b) . Low concentrations of lactococcin B allow leakage of protons and ions, whereas ISO-fold more bacteriocin is needed for leakage of glutamate to occur38, which indicates that pores of different sizes can exist.
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Immunity and resistance to bacteriocins
Immunity to bacteriocins is defined as the production of a so-called immunity protein by a bacterial strain to protect itself.
Nisin immunity and resistance
There are several mechanisms by which bacteria protect themselves against nisin. Nisin resistance (Nis') is not genetically linked to nisin production. In the only study of the mechanism of Nis' carried out so far, which involved the resistance of Bacillus cereus to nisin, the target organism was found to inactivate nisin by modifying one or more of its dehydroamino acid residues by means of a reductase activity42.
Nis" is a spontaneously appearing mutation that causes nisin resistance6. Spontaneous nisin-resistant mutants can be selected by growing nisin-sensitive strains in the presence of nisin, and such mutations have greatly hampered the use of nisin as a food biopreservative.
True nisin immunity is encoded by the nisin operon. Nisi is a lipoprotein that is anchored to the outside of the cytoplasmic membrane43. Cloning and expression of nisi in E. coli or in L. lactis protects the cells from nisin, but the exact mechanism has not been investigated43x44.
Recently 
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indicate that the carboxyl terminus of LciA is on the outside of the cytoplasmic membrane4'. Normal membrane vesicles derived from a strain producing both lactococcin A and the immunity protein do not react with a monoclonal antibody against LciA. This also occurs when lactococcin A is added externally to normal vesicles derived from a strain producing only LciA (Ref. 47) , suggesting that the bacteriocin shields the epitope in LciA from binding the monoclonal antibody. Treatment of membrane vesicles of both immune and sensitive cells with proteinase K made the leucine uptake insensitive to the bacteriocin, suggesting that proteinase K digests both L&A and the putative bacteriocin receptor protein.
LciA could have one of two possible mechanisms of action: the immunity protein might bind to and neutralize the bacteriocin, or alternatively, it might interact with and block the bacteriocin receptor. If LciA were to bind and neutralize lactococcin A, then fusion of immune and sensitive vesicles would result in immune fusion vesicles. However, if LciA were to block the bacteriocin receptor, then the fused vesicles would be sensitive, as the unblocked receptors from the sensitive vesicles would still interact with lactococcin A. Leucine uptake in the fused vesicles is sensitive to the addition of lactococcin A, and so it has been concluded that LciA interacts directly with the lactococcin A receptor to prevent the insertion of the bacteriocin into the cytoplasmic membrane4'.
The 11 kDa LciA protein has been purified by exploiting the physicochemical characteristics derived from its deduced amino acid sequence48. Its amino acid composition and sequence suggest that LciA is not posttranslationally modified. LciA is predicted to have an amphiphilic cx helix with a strong hydrophobic moment of 0.52 between amino acids 29 and 47 (Fig. 3a) 47. These results have been united in a model for LciA topology (Fig. 3b) . The carboxy-terminal residues 48-98 are on the outside of the cell. Residues 29-47 are considered to span the cytoplasmic membrane as an amphiphilic a helix by interacting with another transmembrane protein, possibly the lactococcin A receptor. The amino terminus of LciA is considered to be on the cytoplasmic face of the membrane.
This model explains the observation that only part of the LciA molecule pool is present in the cytoplasmic membrane fraction (see previous discussion). Apparently, this fraction is enough to interact with all the receptors. The cytoplasmic and membrane-associated fractions of LciA may form a continuously available reservoir from which molecules can be drawn rapidly to prevent newly synthesized receptors from interacting with bacteriocin molecules4'.
Conclusions and perspectives
The past few years have seen significant progress in our understanding of nisin and the lactococcins. The structural and immunity genes and the genes encoding the secretion and post-translational modification machinery have been cloned, and we are now beginning to understand the modes of action of nisin and the lactococcins A and B, and the way in which the lactococcin A immunity protein LciA works. The immunity protein probably interacts with the as-yet-unidentified lactococcin A receptor. The molecular details of the mechanism of immunity to nisin will no doubt be resolved in the near future. This knowledge, combined with structure-function studies of the bacteriocins, should allow the construction of molecules with enhanced or altered activities and broader specificities for use as, for example, food preservatives. a tropism for the mucous membranes of the human respiratory tract; indeed, the upper respiratory tract of humans is virtually the sole reservoir for this organism. Although it is usually a commensal, it is potentially pathogenic and is a frequent cause of respiratory tract infection and invasive systemic disease, particularly in children'". Nonencapsulated, so-called nontypeable H. influenzae is important as a cause of upper and lower respiratory tract infections2T3, while encapsulated 2% influenzae, usually of serotype b, is the major cause of invasive systemic disease, such as meningitis'. Infection by H. in/kenzae illustrates the complex interplay that can occur between the host and the pathogen, in a relationship that does not always culminate in disease4.
Two major surface-exposed carbohydrate structures of H. influenzae, the capsule and lipopolysaccharide (LPS), are critical in the pathogenesis of infection'B. Surface determinants that are essential for the organism at one stage of host colonization may be unnecessary or detrimental at a later stage, either because they inhibit specific cell-cell interactions, or because they provide targets for immune attack. The mechanisms that have evolved for phenotypic variation of the capsule and LPS in H. influenzae illustrate some general principles of the adaptive potential of surface determinants and their role in commensal, as well as pathogenic, behaviour. 
Capsule
Definitions of bacterial virulence often include infectivity (minimal infectious dose) and the ability to damage host tissues. These characteristics do not necessarily include a measure of the longer-term fitness (reproductive success) of the bacteriur@. Thus, although virulence factors may be important for survival and spread within and between hosts, pathogenicity determinants may expand the population of bacteria within host microenvironments, even when this does not increase 
